FDA approves robotically-assisted surgical device

The FDA approved a new robotically- assisted surgical device, Senhance System, to facilitate minimally invasive surgeries.

Advertisement

The Senhance System allows surgeons to control three robotic arms while viewing a 3-D image of the surgical site. The system has characteristics such as force feedback, which allows surgeons to “feel” the tissue they are grabbing with the robotic arm; eye tracking, which helps control movement of the surgical tools and laparoscopic controls.

The system is intended for use on adult patients in need of colorectal surgery or gynecological surgery. 

More articles on supply chain:
Philips to suspend some defibrillator manufacturing in US: 5 things to know
FDA approves record number of generics in FY 17
Consumers view drugs as less risky when more side effects are listed in ads

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.